Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001235873 | SCV001408579 | likely pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2019-08-15 | criteria provided, single submitter | clinical testing | This variant results in the deletion of part of exon 9 and exons 10-11 (c.1136_1563+515del) of the EVC gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant has not been reported in the literature in individuals with a EVC-related disease. Loss-of-function variants in EVC are known to be pathogenic (PMID: 23220543). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |